DeepMed Research

Charité - Universitätsmedizin Berlin

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Established: 1710-01-01

Employees: 10K

Market Cap: -

Website: http://www.charite.de

Clinical Trials

Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation

Phase 2

Conditions: Post-Stroke Chronic Aphasia
Anomia (Word-retrieval Impairment)

Interventions: Behavioral: Intensive language therapy

First Posted Date: 2010-10-15

Last Posted Date: 2013-08-27

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 40

Registration Number: NCT01221779

Locations: 🇩🇪
Charite, University Medicine, Dept. of Neurology, Berlin, Germany

Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells

Phase 1

Conditions: Advanced Hematological Malignancies
Indication for Allogeneic Stem Cell Transplantation
Acute Myeloid Leukemias
no HLA-identical Donor Available

Interventions: Biological: Haploidentical transplantation with donor NK cells

First Posted Date: 2010-10-14

Last Posted Date: 2010-10-14

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 30

Registration Number: NCT01220544

Locations: 🇩🇪
Charite Campus Benjamin FRanklin, Medical Clinic III, Department of Hematology/Oncology, Berlin, Germany
🇩🇪
Medical Clinic II, Department of Hematology/Oncology, University of Leipzig, Leipzig, Germany

Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI)

Phase 2

Completed

Conditions: Mild Cognitive Impairment

Interventions: Behavioral: Placebo
Behavioral: resveratrol supplementation
Behavioral: caloric restriction
Behavioral: omega-3 supplementation

First Posted Date: 2010-10-13

Last Posted Date: 2017-07-28

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 330

Registration Number: NCT01219244

Locations: 🇩🇪
Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany

Effects of Physical Activity on the Brain in Impaired Glucose Tolerance (IGT)

Phase 4

Completed

Conditions: Impaired Glucose Tolerance

Interventions: Behavioral: Exercise

First Posted Date: 2010-10-13

Last Posted Date: 2016-03-16

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 46

Registration Number: NCT01219231

Locations: 🇩🇪
Department of Neurology, Charité Universitätsmedizin, Berlin, Germany

Low Grade Inflammation, Gut Microbiota and Barrier Function in Elderly Humans

Early Phase 1

Completed

Conditions: Aged
Healthy

Interventions: Other: Control Group
Dietary Supplement: Probiotic drink

First Posted Date: 2010-10-11

Last Posted Date: 2011-10-28

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 48

Registration Number: NCT01218165

Locations: 🇩🇪
Charité - Universitätsmedizin Berlin, Berlin, Germany

Effects of Emotional Stimulation on the Stress Levels of Healthy Persons

Phase 1

Completed

Conditions: Depression
Somatization Disorder
Anger
Anxiety

Interventions: Other: Emotional stimulation

First Posted Date: 2010-08-24

Last Posted Date: 2010-10-25

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 21

Registration Number: NCT01187797

Locations: 🇩🇪
Charité Universitätsmedizin Berlin, Berlin, Germany

Post Stroke Psychological Distress

Completed

Conditions: Stroke

First Posted Date: 2010-08-24

Last Posted Date: 2025-01-31

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 84

Registration Number: NCT01187342

Locations: 🇩🇪
Charité, Campus Benjamin Franklin, Dep. of Neurology, Berlin, Germany

Effect of Perioperative Hemodynamic Optimization on the Immune Function Parameters of Peripheral Blood Monocytes After Cardiac Surgery

Not Applicable

Conditions: Postoperative Wound Infection
Postoperative Outcome

Interventions: Device: Pulse contour cardiac output device

First Posted Date: 2010-08-19

Last Posted Date: 2013-08-12

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 40

Registration Number: NCT01184430

Locations: 🇩🇪
Department of Anesthesiology and Intensive Care Medicine Campus Charité Mitte / Campus Virchow-Klinikum, Berlin, Germany

Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy

Phase 2

Completed

Conditions: Duchenne Muscular Dystrophy

Interventions: Drug: Placebo
Drug: Epigallocatechin-Gallate

First Posted Date: 2010-08-18

Last Posted Date: 2021-07-29

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 33

Registration Number: NCT01183767

Locations: 🇩🇪
Charité University Berlin, Berlin, Germany
🇩🇪
DRK Kliniken Berlin, Westend, Pädiatrie, Berlin, Germany
🇩🇪
Diakonisches Werk Oldenburg SPZ, Oldenburg, Germany

InductionChemo-Radio-Antibody-Treatment

Phase 2

Completed

Conditions: Squamous Cell Carcinoma of the Neck
Squamous Cell Carcinoma of the Head

Interventions: Drug: TPF induction chemotherapy
Drug: TPF experimental
Radiation: Standard Radiochemotherapy (HART)

First Posted Date: 2010-08-13

Last Posted Date: 2019-01-31

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 94

Registration Number: NCT01181401

Locations: 🇩🇪
Charité Universitaetsmedizin Berlin, CVK, CBF, Berlin, Germany
🇩🇪
University Medical Center Hamburg - Eppendorf, Hamburg, Germany
🇩🇪
Universitätsklinikum Gießen und Marburg, Marburg, Germany

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy